Verdence Capital Advisors LLC Organon & Co. Transaction History

Verdence Capital Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	SELL	$21.42 - $32.08 $67,280 - $100,763	-3,141 Reduced 18.31%	14,016 $329,000
Q4 2022 Jan 20, 2023	SELL	$23.31 - $28.61 $138,997 - $170,601	-5,963 Reduced 25.79%	17,157 $0
Q3 2022 Nov 15, 2022	SELL	$23.4 - $34.25 $113,396 - $165,975	-4,846 Reduced 17.33%	23,120 $541,000
Q2 2022 Aug 08, 2022	SELL	$31.66 - $38.9 $8,073 - $9,919	-255 Reduced 0.9%	27,966 $944,000
Q1 2022 May 02, 2022	SELL	$30.45 - $39.36 $517 - $669	-17 Reduced 0.06%	28,221 $986,000
Q4 2021 Jan 26, 2022	BUY	$28.67 - $37.13 $18,692 - $24,208	652 Added 2.36%	28,238 $860,000
Q3 2021 Nov 12, 2021	BUY	$28.63 - $35.64 $789,787 - $983,165	27,586 New	27,586 $905,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Verdence Capital Advisors LLC with notifications on news.